TRXD - Trxade Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.45
0.00 (0.00%)
At close: 11:58AM EST
Stock chart is not supported by your current browser
Previous Close0.45
Open0.45
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.45 - 0.45
52 Week Range0.22 - 1.00
Volume150
Avg. Volume1,651
Market Cap14.394M
Beta1.36
PE Ratio (TTM)N/A
EPS (TTM)-0.02
Earnings DateNov 3, 2016 - Nov 4, 2016
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.55
Trade prices are not sourced from all markets
  • Trxade Group, Inc. :TRXD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
    Capital Cube3 months ago

    Trxade Group, Inc. :TRXD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Trxade Group, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Trxade Group, Inc. – BioScrip, Inc., CymaBay Therapeutics, Inc. and McKesson Corporation (BIOS-US, CBAY-US and MCK-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)

  • ACCESSWIRE3 months ago

    Trxade Group, Inc. Reports 3rd Consecutive Quarter of Positive Operating Income

    TAMPA, FL / ACCESSWIRE / November 7, 2017 / Trxade Group, Inc. ( OTCQB: TRXD ), a web-based market platform with over 8,300 registered independent pharmacy customers that enables its customers to quickly ...

  • Marketwired4 months ago

    Taglich Brothers Initiates Trxade Group, Inc.

    Taglich Brothers, Inc. announces that it has initiated coverage of Trxade Group, Inc. .Trxade Group, Inc., headquartered in Odessa, Florida, owns and operates a supplier-to-pharmacy Web-based marketplace ...

  • Trxade Group, Inc. :TRXD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 22, 2017
    Capital Cube9 months ago

    Trxade Group, Inc. :TRXD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 22, 2017

    Categories: Yahoo FinanceGet free summary analysis Trxade Group, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Trxade Group, Inc. – BioScrip, Inc., Insmed Incorporated and CymaBay Therapeutics, Inc. (BIOS-US, INSM-US and CBAY-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)

  • Accesswire9 months ago

    Trxade Group, Inc. Achieves First Profitability Quarter Since the Founding of the Company

    TAMPA, FL / ACCESSWIRE / May 16, 2017 / Tr x ade Group, Inc. ( OTCQB: TRXD ), a web-based market platform with over 7,200 registered independent pharmacy customers that enables its customers to quickly ...